Miss Melanie Johnson: The commitments in the Choosing Health White Paper include many of the Health Select Committee's recommendations and positive discussions have taken place between the Department, the Food Standards Agency and the food and drinks industry on these, including approaches to reducing salt, fat and sugar in the diet.
Miss Melanie Johnson: The safety of all medicines and vaccines, including hepatitis B vaccine, is continuously monitored by the Medicines and Healthcare products Regulatory Agency (MHRA), with expert advice from the Committee on Safety of Medicines (CSM). The MHRA uses a variety of data sources for this purpose including reports of suspected adverse drug reactions (ADRs) which are reported through the yellow card...
Miss Melanie Johnson: holding answer 17 March 2005 Before the European Commission brought forward proposals for the Directive on Traditional Herbal Medicinal Products (Directive 2004/24/EC) a study was carried out for the Commission on the then arrangements for regulation of herbal medicines across the European Union (EU). This demonstrated that there were significant differences between member states. The...
Miss Melanie Johnson: holding answer 15 March 2005 Information on emergency readmissions for all ages, within 28 days of discharge, has been collected since 2002–03. Prior to that date, the quarterly information related to the over 75 age group only. Table 1 shows the all ages emergency readmission rates for England for each quarter since quarter one (April to June) 2002. Financial year Quarter Rate of...
Miss Melanie Johnson: Information is already available in the UK Pandemic Influenza Contingency Plan, and is available on the Department's website at: www.dh.gov.uk/pandemicflu.
Miss Melanie Johnson: The United Kingdom, in collaboration with the World Health Organization and international colleagues, is supporting research, developing seedstock for pandemic strains and continuing discussions with manufacturers about the development of a vaccine in the event of an influenza pandemic.
Miss Melanie Johnson: The phases used in the 1997 UK Influenza Pandemic plan are geared to United Kingdom action. The World Health Organization is currently considering modifications to the phases used to the international spread of an influenza pandemic. We understand these are to be published shortly. Any necessary amendments will be made to the UK plan.
Miss Melanie Johnson: The incubation period of influenza ranges from one to seven days, but is commonly two to three days and this range was therefore used for planning purposes. There are no plans to extend this aspect of modelling.
Miss Melanie Johnson: We will consult the National Institute for Clinical Excellence for its views on the use of antivirals when developing the strategy, which will take into account comments received on the plan and be published in due course.
Miss Melanie Johnson: The guidance will be published shortly.
Miss Melanie Johnson: Draft treatment protocols will be published on the Health Protection Agency's website when they are agreed.
Miss Melanie Johnson: Isotretinoin (Roaccutane) is a prescription-only medicine indicated for the treatment of severe acne, such as nodular or conglobate acne or acne at risk of permanent scarring. Its use is limited to specialists in dermatology with expertise in the use of systematic retinoids for the treatment of severe acne and a full understanding of the risks of isotretinoin therapy and monitoring...
Miss Melanie Johnson: The information requested is not collected centrally.
Miss Melanie Johnson: The information is not available in the format requested.
Miss Melanie Johnson: holding answer 14 March 2005 The Department decided to publish data from the mandatory methicillin resistant Staphylococcus aureus (MRSA) surveillance system on a six-monthly basis so that the public could be informed more frequently about the record of their local national health service trusts. The decision was taken in February this year, after consulting the Health Protection Agency, to...
Miss Melanie Johnson: We understand that the British HIV Association will publish new guidelines on the management of HIV infection in pregnant women and the prevention of mother-to-child transmission in July 2005.
Miss Melanie Johnson: The information requested is not yet available. Data for 2004–05 will be available in the autumn.
Miss Melanie Johnson: The recommendations from Joint Committee on Vaccinations and Immunisations are published on the Department's website at: www.advisorybodies.doh.gov.uk/jcvi/mins01nov02.htm It is a matter for clinical governance on how these recommendations are implemented.
Miss Melanie Johnson: We do not routinely collect this information.
Miss Melanie Johnson: The Department has invested £26 million since 2002–03 to pump-prime improvements to sexual health services. It is for the national health service locally to decide how this money can best be spent in order to meet local needs, and no information is held centrally on how the allocations are used by individual trusts. A further £15 million capital funding was also made available in...